These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31938827)

  • 21. Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.
    Cataldo MA; Granata G; Petrosillo N
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1027-1040. PubMed ID: 28980505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of Clostridium difficile infection.
    Korman TM
    Semin Respir Crit Care Med; 2015 Feb; 36(1):31-43. PubMed ID: 25643269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes.
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Nguyen A; Asch J; Hoda D
    Clin Transplant; 2019 Nov; 33(11):e13712. PubMed ID: 31532030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2019 update of the WSES guidelines for management of
    Sartelli M; Di Bella S; McFarland LV; Khanna S; Furuya-Kanamori L; Abuzeid N; Abu-Zidan FM; Ansaloni L; Augustin G; Bala M; Ben-Ishay O; Biffl WL; Brecher SM; Camacho-Ortiz A; Caínzos MA; Chan S; Cherry-Bukowiec JR; Clanton J; Coccolini F; Cocuz ME; Coimbra R; Cortese F; Cui Y; Czepiel J; Demetrashvili Z; Di Carlo I; Di Saverio S; Dumitru IM; Eckmann C; Eiland EH; Forrester JD; Fraga GP; Frossard JL; Fry DE; Galeiras R; Ghnnam W; Gomes CA; Griffiths EA; Guirao X; Ahmed MH; Herzog T; Kim JI; Iqbal T; Isik A; Itani KMF; Labricciosa FM; Lee YY; Juang P; Karamarkovic A; Kim PK; Kluger Y; Leppaniemi A; Lohsiriwat V; Machain GM; Marwah S; Mazuski JE; Metan G; Moore EE; Moore FA; Ordoñez CA; Pagani L; Petrosillo N; Portela F; Rasa K; Rems M; Sakakushev BE; Segovia-Lohse H; Sganga G; Shelat VG; Spigaglia P; Tattevin P; Tranà C; Urbánek L; Ulrych J; Viale P; Baiocchi GL; Catena F
    World J Emerg Surg; 2019; 14():8. PubMed ID: 30858872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. World Society of Emergency Surgery-American Association for the Surgery of Trauma Guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients: An executive summary.
    Sartelli M; Ansaloni L; Biffl WA; Coccolini F; De Simone B; Leppaniemi A; Kluger Y; Tolonen M; Moore EE; Catena F
    J Trauma Acute Care Surg; 2021 Aug; 91(2):422-426. PubMed ID: 33783420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on Treatment of Clostridioides difficile Infection.
    Cho JM; Pardi DS; Khanna S
    Mayo Clin Proc; 2020 Apr; 95(4):758-769. PubMed ID: 32247350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Infection due to Clostridium (Clostridioides) difficile.
    Krishna A; Chopra T
    Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future trends in clostridioides (clostridium) difficile infection management.
    Khanna S; Gerding DN
    Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
    Alnimr A; Alwazzeh MJ; Al-Ameer A
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging drugs for the treatment of clostridium difficile.
    Cammarota G; Gallo A; Ianiro G; Montalto M
    Expert Opin Emerg Drugs; 2019 Mar; 24(1):17-28. PubMed ID: 30841760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
    Mullane KM; Dubberke ER;
    Clin Transplant; 2019 Sep; 33(9):e13564. PubMed ID: 31002420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
    Haber SL; Raney CRK; Larson TL; Lau JP
    Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clostridium difficile in the intensive care unit].
    Prechter F; Stallmach A
    Med Klin Intensivmed Notfmed; 2020 Mar; 115(2):81-87. PubMed ID: 29995234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridioides (Clostridium) difficile infection: current and alternative therapeutic strategies.
    Gil F; Calderón IL; Fuentes JA; Paredes-Sabja D
    Future Microbiol; 2018 Mar; 13():469-482. PubMed ID: 29464969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
    Di Bella S; Nisii C; Petrosillo N
    Int J Antimicrob Agents; 2015 Jul; 46(1):8-12. PubMed ID: 25982915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.